DART
发表于 2025-3-21 16:49:00
书目名称Cancer Drug Safety and Public Health Policy影响因子(影响力)<br> http://impactfactor.cn/2024/if/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy影响因子(影响力)学科排名<br> http://impactfactor.cn/2024/ifr/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy网络公开度<br> http://impactfactor.cn/2024/at/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy网络公开度学科排名<br> http://impactfactor.cn/2024/atr/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy被引频次<br> http://impactfactor.cn/2024/tc/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy被引频次学科排名<br> http://impactfactor.cn/2024/tcr/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy年度引用<br> http://impactfactor.cn/2024/ii/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy年度引用学科排名<br> http://impactfactor.cn/2024/iir/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy读者反馈<br> http://impactfactor.cn/2024/5y/?ISSN=BK0221097<br><br> <br><br>书目名称Cancer Drug Safety and Public Health Policy读者反馈学科排名<br> http://impactfactor.cn/2024/5yr/?ISSN=BK0221097<br><br> <br><br>
展览
发表于 2025-3-21 21:47:44
Book 2022nalysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention – these fines are playing an important role in changing the landscape for pharmaceutical safety
高兴一回
发表于 2025-3-22 03:17:24
http://reply.papertrans.cn/23/2211/221097/221097_3.png
充满装饰
发表于 2025-3-22 06:28:11
http://reply.papertrans.cn/23/2211/221097/221097_4.png
慢跑
发表于 2025-3-22 09:18:55
http://reply.papertrans.cn/23/2211/221097/221097_5.png
nocturnal
发表于 2025-3-22 16:18:36
http://reply.papertrans.cn/23/2211/221097/221097_6.png
nocturnal
发表于 2025-3-22 17:17:44
https://doi.org/10.1007/978-3-540-87866-7 Ticlopidine, and Thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012;38(08):905–907. .). Prevailing opinion suggests that low reporting rates reflect time constraints.
慢跑
发表于 2025-3-22 21:34:33
http://reply.papertrans.cn/23/2211/221097/221097_8.png
chalice
发表于 2025-3-23 04:00:48
http://reply.papertrans.cn/23/2211/221097/221097_9.png
预定
发表于 2025-3-23 07:05:39
http://reply.papertrans.cn/23/2211/221097/221097_10.png